Monday, July 14, 2014 11:24:07 AM
Here's some words for the CEO from the June 30th Release
"He explains, "I want everyone to know that shareholder value is very important to me, and I will do whatever I can to increase the value of this company for its shareholders to the level it really should be."
Overall the company is focusing on its strategy for the next twelve months in all areas of the business, not just the marketing and release of new products, but the reduction of shares resulting from past dilution and whatever else it takes to help Manzo Pharmaceuticals provide shareholder value, while bringing much needed remedies and treatments to the people who need them."
Management has been active and will continue to be. We have a gem here
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM